Atom Grants
Discover
  • Dashboard
  • Search
  • Deep Research
  • Favorites
  • Projects

    Diabetes Research Centers (P30 Clinical Trial Optional)

    Limited submission

    NIDDK plans to fund Diabetes Research Centers (P30) to foster collaboration, mentoring, and innovative research resources for advancing diabetes and metabolic disorder research.

    OverviewSimilar Grants
    OverviewSimilar Grants

    Funder: National Institutes of Health

    Due Dates: March 10, 2026 (Applications) | January 27, 2027 (Applications)

    Funding Amounts: $1,000,000 annual award ceiling; maximum project period of five years; $18.2 million total program funding

    Summary: Supports Diabetes Research Centers providing shared research cores, pilot studies, and enrichment activities for diabetes and related endocrine and metabolic research.

    Key Information: Only one application per institution; an existing research base of at least $12 million annually is required.


    Description

    The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), part of NIH, supports Diabetes Research Centers through P30 Center Core Grants. Centers bring together basic and clinical investigators studying diabetes, its complications, and related endocrine and metabolic diseases. Shared specialized research cores and Pilot and Feasibility (P&F) programs are intended to enable accomplishments beyond those possible through individual research project grants alone.

    The program promotes preclinical, clinical, and interdisciplinary research leading to better understanding, prevention, diagnosis, and treatment. New scientific approaches, unique themes, and innovative resources are encouraged. Priorities include collaboration with other NIDDK-funded programs, effective use of existing resources, and mentoring future diabetes researchers. Applications may propose clinical trials, but trials are not required.


    Atom

    See the full grant listing

    Sign in to view full eligibility details, sources, similar grants, and AI-powered analysis.